Adverse Drug Events
An adverse drug event (ADE) is an injury a patient incurs
resulting from the use of a drug. In hospitals, examples of adverse drug events
include medication errors such as accidental overdose or providing a drug to
the wrong patient or by adverse drug reactions, such as an allergic reaction. According
to the U.S. Department of Health and Human Services, patients in hospitals
experience approximately 1.9 million adverse drug events annually, from events
that cause little or no harm to those that result in death.
Minnesota hospitals take the prevention of adverse health
events seriously and are involved in many initiatives to reduce the number of adverse drug events in our
hospitals. An adverse drug event advisory group has developed a road map based on evidence-based best practices focusing on anti-coagulants, hypoglycemic agents and opioids. The work of the advisory group has been highly anticipated nationally.
The ADE road map will be a key component of the Partnership for Patients’ Medication Safety Affinity
Group's (MSAG) support of the improved safety in the use of anticoagulants, insulin and oral hypoglycemic agents. MSAG, comprised of 24 Hospital Engagement Networks (HEN) and over
2,900 hospitals, is focused on collecting and disseminating results, best
practices, and implementation strategies to improve medication safety.
Download the MHA "Road Map to a Medication Safety Program" and following components of the road map:
– Anticoagulation Agent Adverse Drug Event Gap Analysis;
– Hypoglycemic Agent Adverse Drug Event Gap Analysis;
– Opioid Adverse Drug Event Prevention Gap Analysis; and
– VTE Prevention Strategies Gap Analysis.
Access the tool kit of best practices and resources on the bottom of this web page to guide you in your efforts.
Adverse drug events are one of the 10 areas of
focus being addressed
through the Partnership for Patients Hospital Engagement Network. The Partnership estimates that 50 percent of all adverse drug events in
hospitals each year are preventable and hospitals are working to reduce ADEs by
40 percent by 2013.